Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03673800
Other study ID # P170601
Secondary ID 2017-A01666-47
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 18, 2019
Est. completion date March 2024

Study information

Verified date February 2024
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An online single blinding, randomized, comparative therapeutic web-based, controlled trial. The main objective of the study is to assess the clinical efficacy of an online computerized cognitive training program targeted on cognitive control, namely on inhibition, measured with the PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks, as compared to a control program with a similar setting.


Description:

Cognitive training is currently used in brain damaged patients and in some psychiatric conditions, like schizophrenia or depression. Very few cognitive training programs have been published and tested in addictive disorders. Training online is currently proposed in standard care, and is listed as recommended activities in daily hospitalization in addiction specialized out-settings in France. The purpose of this research is to test the efficacy of an online intervention in gambling addiction through cognitive training targeting cognitive control inhibition. The experimental Intervention (Cognitive Training) is a computerized cognitive training targeting inhibitory control of motor response (Scientific Brain Training®).The tasks included in the program have been selected and modified to target inhibition. Control intervention is a sensorial program with a similar format targeting visual acuity. This is not a cognitive program, and can be considered as neutral in the addiction field. An optional guidance by phone performed by a trained neuropsychologist is proposed to the included subjects in both groups, up to15 minutes twice a week. Study design: A therapeutic web-based, comparative, randomized controlled trial, 2 arms, single blinding, with 52 weeks follow-up: - a 14 weeks patient follow up (6 weeks for efficacy assessment and maintenance at 14 weeks). - 52 weeks gambling account based data extracted from the ARJEL database in last 4 weeks before baseline, week 6, week 14 and week 52. Population of study participants : Problem gamblers who will contact the responsible of the study. Schedule for the study : - Duration of inclusion period: 8 months - Duration of patient participation: 52 weeks (12 months) including 14 weeks of active gambler participation and up to 52 weeks for the collection of gambler data from the ARJEL database. - Total research duration: 20 months Main objective : To assess the clinical efficacy of an online computerized cognitive training program targeted on cognitive control, namely on inhibition, measured with the PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks. Secondary objectives of the study are: - to assess the efficacy on the evolution of the gambling behaviour assessed by the account player based gambling data, at 6, 14and 52 weeks. - to assess the efficacy on the evolution of the self-reported gambling practice, and of quality of life at 0, 6 and 14 weeks. - to assess the efficacy on the evolution of inhibition performance at the neuropsychological level at 0, 6 and 14, weeks. - We will also assess the acceptability of this program and the preferred level of guidance of the non-treatment seeking problem gamblers as factor of response. Statistical analysis:The change in PGSI-recent total score over 6 weeks will be compared with the student's t-test. If the test application conditions are not met, a Wilcoxon test will be applied.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 200
Est. completion date March 2024
Est. primary completion date June 6, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria 1. Over 18 years old gamblers 2. Willing to share his/her first name, last name, exact birthdate, and exact place of birth (city + department). These informations are needed to extract ARJEL player account based gambling data, to avoid any doubloon or homonym. 3. PGSI-recent = 5. 4. Recipient or beneficiary of the French social security system and resident in France. Non-inclusion criteria 1. Gamblers cannot speak or understand French

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Experimental Group
Cognitive web-based training : 2 up to 30 minutes sessions a week during 6 weeks. Optional debriefing by a neuropsychologist up to 15 minutes twice a week
Control Group
Sensorial web-based training : 2 up to 30 minutes sessions a week during 6 weeks. Optional debriefing by a neuropsychologist up to 15 minutes twice a week

Locations

Country Name City State
France Paul Brousse Hospital Villejuif

Sponsors (2)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris ARJEL (Autorité de Régulation des Jeux En Ligne)

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The change over 6 weeks in Problem gambling severity index (PGSI)-recent total score, collected by internet PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks Change from baseline at 6 weeks
Secondary Problem gambling severity index - recent (PGSI) Between baseline (T0) , and 14 weeks (T2)
Secondary Short form of Urgency, Premeditation, Perseverance, Sensation seeking, and Positive urgency (UPPS-P) Impulsive behavior scale Impulsivity scale Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Secondary Time Line Follow Back (TLFB) -gambling Money and time spent gambling including offline gambling Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Secondary EuroQol five dimensions questionnaire (EQ-5D) Health related quality of life self-questionnaire Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Secondary Gambling Quality of Life Scale (GQoLS) Health related quality of life self-questionnaire specific to gambling disorder Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Secondary Neuropsychological assessment: Stop Signal Task (SST) Cognitive task assessing inhibition Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Secondary Total Deposit Total Deposit assessed by the account player based gambling data (ARJEL database) In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Total stake by game Total stake by game assessed by the account player based gambling data (ARJEL database) In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Compulsivity Compulsivity (as defined by three consecutive deposits in a 12-hour period of time) assessed by the account player based gambling data (ARJEL database) In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Number of deposit in the hour following a stake Number of deposit in the hour following a stake assessed by the account player based gambling data (ARJEL database) In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Total loss by game Total loss by game assessed by the account player based gambling data (ARJEL database) In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Number of sessions (all games) Number of sessions (all games) in a clinical meaning assessed by the account player based gambling data (ARJEL database) Session is defined as gambling behaviour in itself; we'll consider the beginning of a session when a gambling action occurs after no gambling action since at least 30 minutes, and the end of the gambling session a gambling action followed by no gambling action during 30 minutes. In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Session duration (poker only) Session duration (poker only) assessed by the account player based gambling data (ARJEL database) In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Gambling time slot Gambling time slot assessed by the account player based gambling data (ARJEL database).
The time slots are divided as follows:
0:00 to 3 :59
4:00 to 7:59
8:00 to 11:59
12:00 to 15:59
16:00 to 19:59
20:00 to 23:59
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Secondary Acceptability of the online program assessed by the number of training session At 6 week (T1)
Secondary Acceptability of the online program assessed by the length of training session At 6 week (T1)
Secondary Level of guidance assessed by the number of phone session Number of debriefing by phone sessions At 6 week (T1)
Secondary Level of guidance assessed by the length of phone session Length of debriefing by phone sessions At 6 week (T1)
See also
  Status Clinical Trial Phase
Completed NCT02590211 - Poker, Skills and Associated Problems N/A
Completed NCT02203786 - D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement Phase 2
Completed NCT05051085 - Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling N/A
Completed NCT01215357 - Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble Phase 2
Terminated NCT00245583 - Topiramate in the Treatment of Pathological Gambling Phase 3
Completed NCT04842461 - Mental Health, Addictions and Biomarkers in High Athletes Performance
Not yet recruiting NCT03280966 - Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder Phase 2
Active, not recruiting NCT01743092 - Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment N/A
Active, not recruiting NCT01528982 - Susceptibility to Pathological Gambling N/A
Terminated NCT00211822 - Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD) N/A
Completed NCT01381250 - Effects of Internet-based Treatment of Pathological Gambling N/A
Completed NCT05506384 - Treatment Study for Problematic Gaming and Gambling N/A
Enrolling by invitation NCT03464838 - Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder N/A
Terminated NCT01560351 - Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study N/A
Completed NCT00580567 - Impulsivity in Pathological Gambling N/A
Completed NCT02240485 - Integrative Couple Treatment for Pathological Gambling N/A
Withdrawn NCT01340274 - Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling Phase 2
Recruiting NCT02491996 - The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers N/A
Recruiting NCT01154712 - Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling Phase 1
Completed NCT00927563 - Tolcapone Treatment of Pathological Gambling Phase 2